Manager, Financial Planning & Analysis

About Spy Glass Pharma:

At Spy Glass Pharma, we are focused on improving and preserving the vision of patients suffering from chronic eye conditions, while minimizing the impact on their daily lives. We aim to achieve this by developing cutting‑edge long‑term drug delivery products to address common causes of blindness and getting these products to the patients that need them.

We have built a team of driven professionals with diverse expertise in ophthalmic products and drug delivery. Our accomplished scientists and engineers work alongside a seasoned leadership team with extensive experience in ophthalmology and a history of commercial success. Our unifying mantra, “We create for patients” doesn’t just live on our walls but drives our decision making as we build the company, creating the products, processes and culture that make it happen.

This team has delivered a solid foundation of development and clinical data, enabling over $200 million in funding to date with several top‑tier venture partners. We are building confidence in the performance of our lead product going into Phase 3 clinical trials.

We are seeking an experienced Financial Planning & Analysis (FP&A) Manager to join our growing Finance team at Spy Glass Pharma. Reporting to the Vice President, Finance, this role will be responsible for leading budgeting, forecasting, long‑range planning, and financial analysis activities to support executive decision‑making in a publicly traded biotechnology company.

The FP&A Manager will partner cross‑functionally to provide financial visibility, ensure fiscal discipline, and support strategic initiatives as the company advances through Phase 3 clinical trials and prepares for commercialization. The ideal candidate brings strong public company experience, technical financial rigor, and the ability to operate effectively in a fast‑paced, high‑growth environment.

• Lead the annual budgeting process and quarterly reforecast cycles, partnering with functional leaders to ensure accurate and aligned financial plans.
• Develop and maintain long‑range financial models to support strategic planning, capital allocation, and scenario analysis.
• Prepare monthly and quarterly financial reporting packages for executive leadership, including variance analysis and key performance metrics.
• Support public company reporting requirements, including preparation of materials supporting SEC filings, earnings releases, and investor communications.
• Partner with Clinical Operations, R&D, Manufacturing, and G&A to track program spend, headcount planning, and key operational drivers.
• Analyze clinical trial budgets, CRO contracts, manufacturing costs, and other program‑level expenditures to ensure alignment with approved plans.
• Provide financial modeling support for business development activities, strategic initiatives, and capital planning.
• Monitor cash flow projections and collaborate with Accounting to ensure accurate financial reporting and controls.
• Enhance financial processes, tools, and systems to improve forecasting accuracy, reporting efficiency, and scalability.
• Support Board of Directors and Audit Committee financial materials preparation as needed.
• Ensure compliance with internal controls and SOX‑related processes applicable to a publicly traded company.
• Contribute to building a high‑performing, collaborative finance function aligned with company growth objectives.

• Bachelor’s degree in Finance, Accounting, Economics, or related field preferred; MBA or CPA preferred.
• Minimum of 5–8 years of progressive experience in FP&A, corporate finance, or investment banking.
• Prior experience in a publicly traded company environment preferred; experience supporting SEC reporting and earnings processes strongly preferred.
• Experience in biotechnology, pharmaceutical, medical device, or life sciences industry highly preferred.
• Strong financial modeling skills, including experience building and maintaining complex operating and cash flow models.
• Understanding of GAAP, internal controls, and SOX compliance requirements.
• Ability to partner effectively with cross‑functional…